Literature DB >> 7031547

Considerations of antibiotic therapy during pregnancy.

R H Schwarz.   

Abstract

The use of antibiotics in pregnancy requires that the clinician consider both toxicity to and pharmacokinetics for mother and fetus. Although most adverse reactions to antibiotics in the adult are not modified by pregnancy, those to tetracycline and erythromycin estolate are the exceptions. Tetracycline is contraindicated throughout pregnancy because of fetal effects, whereas sulfa preparations, trimethoprim, and chloramphenicol are contraindicated only at specific times during gestation. The pharmacokinetics of antibiotics in the mother are such that lower serum concentrations are achieved for a given dose, which may be important in serious or resistant infections. Fetal kinetics are such that transfer to amniotic fluid and distribution within the fetus may not provide adequate protection for the fetus in cases of chorioamnionitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7031547

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Use and safety of antimicrobial agents during pregnancy.

Authors:  A W Chow; P J Jewesson
Journal:  West J Med       Date:  1987-06

2.  A short review of perinatal pharmacology.

Authors:  T Rosen; M S Schimmel
Journal:  Bull N Y Acad Med       Date:  1983-09

3.  Transient, inducible, placenta-specific gene expression in mice.

Authors:  Xiujun Fan; Matthew Petitt; Matthew Gamboa; Mei Huang; Sabita Dhal; Maurice L Druzin; Joseph C Wu; Yanru Chen-Tsai; Nihar R Nayak
Journal:  Endocrinology       Date:  2012-09-25       Impact factor: 4.736

Review 4.  Integrated defense system overlaps as a disease model: with examples for multiple chemical sensitivity.

Authors:  S C Rowat
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

5.  Placental anomalies and fetal loss in mice, after administration of doxycycline in food for tet-system activation.

Authors:  René Moutier; Françoise Tchang; Stéphane M Caucheteux; Colette Kanellopoulos-Langevin
Journal:  Transgenic Res       Date:  2003-06       Impact factor: 2.788

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.